Immedica Pharma’s Acquisition of Pegzilarginase Assets from Aeglea

Leila Ahmed
Tagged:

Davis Polk & Wardwell advised Immedica Pharma AB on the transaction.Immedica Pharma AB announced its acquisition from Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) of all assets related to…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now